Health Catalyst HCAT Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Health Catalyst in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Health Catalyst's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Health Catalyst's allowance for doubtful accounts receivable (current)?
- Health Catalyst (HCAT) reported allowance for doubtful accounts receivable (current) of $4.2M in Q1 2026.
- How has Health Catalyst's allowance for doubtful accounts receivable (current) changed year-over-year?
- Health Catalyst's allowance for doubtful accounts receivable (current) increased by 40.0% year-over-year, from $3M to $4.2M.
- What is the long-term trend for Health Catalyst's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Health Catalyst's allowance for doubtful accounts receivable (current) has grown at a 25.3% compound annual growth rate (CAGR), from $1.2M to $3.7M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.